RACHEL BRINKERHOFF: Open Payments
NPI 1598462152 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,104 in 141 payments from 35 companies in 2025. Trend: 2023 $2,777 · 2024 $4,260 · 2025 $3,104
Food & beverage: $2,929Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $509 |
| Lilly USA, LLC | 6 | $228 |
| JAZZ PHARMACEUTICALS INC. | 9 | $210 |
| Neurocrine BioSciences, Inc. | 3 | $181 |
| Novartis Pharmaceuticals Corporation | 9 | $175 |
| EMD Serono, Inc. | 4 | $169 |
| PFIZER INC. | 15 | $143 |
| MDD US Operations, LLC | 3 | $124 |
| Mallinckrodt Hospital Products Inc. | 4 | $120 |
| SK Life Science, Inc. | 3 | $87 |
Products named: INGREZZA, QULIPTA, KESIMPTA, BOTOX, XYWAV, ACTHAR, NURTEC ODT, KISUNLA.
Industry payments across VA — which companies pay providers there.
